Gentian Diagnostics looks forward to attend the 39th Nordic Congress of Clinical Chemistry in Stockholm. The congress will take place in Stockholm, Sweden 17-20 September 2024.
Gentian is a Norwegian IVD company founded in 2001 that specialises in development and manufacturing of turbidimetric assays that empower clinical lab professionals to achieve greater operational efficiency. The current portfolio and pipeline of diagnostic reagents span areas of kidney disease, cardiac disease, inflammation, infection and veterinary medicine. Our goal is to make our products compatible with all major clinical chemistry platforms, allowing laboratories to expand their test menus without the need for additional instruments.
In the Nordics, products are distributed to end users via Gentian Diagnostics AB, the Swedish affiliate, which besides products from Gentian also distributes products from BÜHLMANN Laboratories AG and Mindray.
quantitative determination of canine CRP in dog plasma and serum
|
fCAL® turbo - Faecal Calprotectin |
GanglioCombi® MAG ELISA |
Flow CAST® Basophil activation test |
Mindray provides robust, cost efficient and easy-to-use laboratory solutions for chemistry, chemiluminescence immunoassay and hematology.
To ensure continuous compliance for existing and pipeline products, Gentian started its preparing for implementation of the European In-Vitro Diagnostic Regulation, EU 2017/746 in 2017. The Gentian Cystatin C and GCAL® assays are since September 2022 IVDR certified by TüV SÜD.
BÜHLMANN has also been successful in implementing the transfer of their IVDD products to IVDR.
Are you interested in adding our assays to your test menu please fill out the form below or send an email to marketing@gentian.com